Conference
Phase I Trial of Selinexor (KPT-330), A First-In-Class Oral Selective Inhibitor Of Nuclear Export (SINE) In Patients (pts) With Advanced Acute Myelogenous Leukemia (AML)
Authors
Savona M; Garzon R; Brown PDN; Yee K; Lancet JE; Gutierrez M; Gabrail N; Mau-Sorensen M; Baz R; Byrd JC
Volume
122
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 15, 2013
Name of conference
55th Annual Meeting of the American-Society-of-Hematology
Conference place
LA, New Orleans
Conference start date
December 7, 2013
Conference end date
December 10, 2013
Conference proceedings
BLOOD
Issue
21
ISSN
0006-4971